Increased neutrophil count in nascent metabolic syndrome.

BACKGROUND The alarming increase in the prevalence of metabolic syndrome globally demands serious attention. Recently, we reported increased cellular dysfunction of subcutaneous adipose tissue and monocytes contributing to the insulin resistance and increased inflammation in nascent metabolic syndrome. The major circulating leukocyte is the neutrophil (polymorphonuclear neutrophil, PMN). The aim of the study was to evaluate leukocyte levels in nascent metabolic syndrome uncomplicated by diabetes or cardiovascular disease (CVD). METHODS In this study, we compared nascent metabolic syndrome (n=63) versus control subjects (n=44). Fasting blood was collected for complete blood count, insulin, glucose, high-sensitivity C-reactive protein (hsCRP), and nitrotyrosine. RESULTS The white blood cell (WBC) and neutrophil counts were significantly increased in metabolic syndrome compared to controls following adjustment for age, gender, and adiposity. There were significant correlations between neutrophil counts with homeostasis model assessment of insulin resistance (HOMA-IR) and hsCRP, (r=0.29, P=0.004 and r=0.35, P=0.0004, respectively). Similarly the correlations of WBC counts were significant with HOMA-IR and hsCRP (r=0.22, P=0.03 and r=0.31, P=0.0014, respectively). CONCLUSION These findings suggest that significantly elevated WBCs due to increased neutrophil counts in nascent metabolic syndrome could contribute to the increased risk for both diabetes and CVD.

[1]  I. Tanboğa,et al.  Correlation of Neutrophil to Lymphocyte Ratio With the Presence and Severity of Metabolic Syndrome , 2014, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[2]  B. Adams-Huet,et al.  Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[3]  Oliver Soehnlein,et al.  Multiple roles for neutrophils in atherosclerosis. , 2012, Circulation research.

[4]  S. Devaraj,et al.  Increased Toll-Like Receptor Activity in Patients With Metabolic Syndrome , 2012, Diabetes Care.

[5]  S. Devaraj,et al.  Adipose tissue dysregulation in patients with metabolic syndrome. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  S. Devaraj,et al.  Inflammation and Metabolic Syndrome , 2011 .

[7]  G. Liguori,et al.  Persistent Increase of Prevalence of Metabolic Syndrome Among U.S. Adults: NHANES III to NHANES 1999–2006 , 2010, Diabetes Care.

[8]  J. Dixon,et al.  Obesity and the White Blood Cell Count: Changes with Sustained Weight Loss , 2006, Obesity surgery.

[9]  J. A. Kim,et al.  Association of metabolic syndrome with white blood cell subtype and red blood cells. , 2006, Endocrine journal.

[10]  Stanley L Hazen,et al.  ATVB in Focus Redox Mechanisms in Blood Vessels , 2005 .

[11]  S. Kunkel,et al.  Neutrophil-derived cytokines: potential therapeutic targets in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[12]  Christian Weyer,et al.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[13]  L. Becker,et al.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[14]  F. Bazzoni,et al.  The neutrophil as a cellular source of chemokines , 2000, Immunological reviews.